Karnataka Chemists Association Calls for Overhaul of State Drugs Control Department

When the Karnataka Chemists Association (KCA) walked into the Minister’s office last week, they weren’t just bearing a stack of petitions – they carried the weight of a thousand small‑scale pharmacies that feel squeezed by an aging, sometimes opaque, regulatory framework.

“We’re not asking for special treatment,” said Dr. Ramesh Kumar, president of the KCA, his voice cracking a little as he spoke about the daily grind of his members. “What we need is a system that’s clear, predictable, and—most importantly—fair.”

At the heart of the association’s demand lies a three‑point agenda: first, a revamp of the drug‑licensing process to cut down the months‑long waiting periods that stall new pharmacies; second, the introduction of a digitised inspection schedule that removes the feeling of arbitrary raids; and third, a robust grievance‑redressal portal where pharmacists can lodge complaints without fearing retaliation.

The current scenario, according to many shop owners, resembles a maze. “Every time we get a call for an inspection, we scramble,” narrated Meera Sharma, who runs a family pharmacy in Mysuru. “Sometimes it’s a surprise visit; other times, the notice arrives weeks after the inspection, leaving us no time to prepare.” Such unpredictability, the KCA argues, not only disrupts business but can also jeopardise patient care when essential medicines are temporarily unavailable.

Beyond logistics, the association highlighted a glaring gap in communication. “We receive circulars in Hindi or English, but many of our members are more comfortable in Kannada,” noted Kumar. “A multilingual approach would go a long way in ensuring compliance rather than mere obedience.”

In response, the Drugs Control Department (DCD) released a brief statement acknowledging the concerns and promising to review existing protocols. “We are committed to modernising our processes and will engage with stakeholder groups,” the statement read, though it offered no concrete timeline.

Industry experts see this as a pivotal moment. Dr. Ananya Rao, a policy analyst at the Indian Institute of Public Health, pointed out that Karnataka’s pharmaceutical sector contributes roughly 8 % to the state’s GDP. “Any bottleneck in the supply chain, especially at the retail level, ripples through the entire health ecosystem,” she explained. “Reforms that streamline licensing and inspections can boost confidence, attract investment, and ultimately improve access to medicines for the common citizen.”

Critics, however, caution against moving too quickly. Some senior officials within the DCD worry that a rapid digitisation could overlook on‑ground realities, especially in remote districts where internet connectivity remains patchy.

To bridge this divide, the KCA has proposed a pilot program in three districts—Bangalore Urban, Dakshina Kannada, and Chitradurga—where digital tools would be tested alongside traditional methods. “If it works, we scale; if not, we adapt,” said Kumar, smiling wryly at the irony of ‘trial and error’ in bureaucracy.

The association also called for regular workshops, where regulators and pharmacists could meet face‑to‑face, demystifying procedures and building trust. “A little dialogue goes a long way,” Sharma added, recalling a past workshop that helped her navigate a confusing amendment to the Drug and Cosmetics Act.

As the debate unfolds, one thing is clear: the chemistry between Karnataka’s pharmacists and its regulators needs a catalyst. Whether the proposed reforms will spark that reaction remains to be seen, but the KCA’s plea has certainly put the conversation front and centre in the state’s health‑policy arena.